Latest News Archive
Please select Category, Year, and then Month to display items
01 March 2023
|
Story Alicia Pienaar
Prof Mathys Labuschagne is the Head of the Clinical Simulation and Skills Unit within the School of Biomedical Sciences in the Faculty of Health Sciences
The Dean of the Faculty of Health Sciences, Prof Gert van Zyl, invites you to the inaugural lecture of Prof Mathys Labuschagne, Head of the Clinical Simulation and Skills Unit within the School of Biomedical Sciences in the Faculty of Health Sciences.
Subject: Clinical Simulation: Quo Vadis?
Venue: Auditorium, Equitas Building, Bloemfontein Campus
Date: 8 March 2023
Time: 17:30
RSVP on or before Friday 3 March 2023
Light refreshments will be served after the inaugural lecture.
About Prof M Labuschagne
Prof Mathys Labuschagne is the Head of the Clinical Simulation and Skills Unit within the School of Biomedical Sciences in the Faculty of Health Sciences at the University of the Free State. He completed his MB ChB degree and qualified as an ophthalmologist in 2006.
He developed an interest in health professions education and obtained a PhD in Health Professions Education in June 2012. The title of his thesis was: Clinical Simulation to enhance undergraduate medical education and training at the University of the Free State.
Prof Labuschagne was appointed Head of the Clinical Simulation and Skills Unit at the University of the Free State. The facility is utilised for undergraduate and postgraduate clinical simulation training, as well as interprofessional training and research. He has a special interest in simulation as training tool, precision skills training, and mastery of learning and simulation as tool to prepare students for interprofessional education and collaborative practice.
Prof Labuschagne is part of a multi-institutional consortium that developed the MySkills Medic app. It is a clinical procedural skills application aimed at graduating medical students, interns, and community-service doctors. He was appointed as a member of the Ophthalmology Foundation Education Simulation Subcommittee (affiliate of the International Council of Ophthalmology) tasked with developing a white paper to guide simulation training for ophthalmologists. He is involved in postgraduate supervision for master’s and PhD students in HPE.
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”